FY2024 Earnings Estimate for Appian Issued By KeyCorp

Appian Co. (NASDAQ:APPN) – Research analysts at KeyCorp issued their FY2024 earnings estimates for Appian in a research report issued to clients and investors on Monday, January 13th. KeyCorp analyst D. Au anticipates that the company will post earnings of ($0.90) per share for the year. KeyCorp currently has a “Sector Weight” rating on the stock. The consensus estimate for Appian’s current full-year earnings is ($0.89) per share. KeyCorp also issued estimates for Appian’s Q4 2024 earnings at ($0.14) EPS, Q1 2025 earnings at ($0.08) EPS, Q2 2025 earnings at ($0.20) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.34) EPS and FY2026 earnings at $0.11 EPS.

A number of other brokerages have also recently weighed in on APPN. DA Davidson restated a “neutral” rating and issued a $33.00 price objective on shares of Appian in a report on Monday, October 14th. Barclays lifted their price objective on shares of Appian from $34.00 to $37.00 and gave the company an “underweight” rating in a report on Friday, December 6th. Finally, Scotiabank initiated coverage on shares of Appian in a report on Monday, January 6th. They issued a “sector perform” rating and a $37.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $40.17.

Appian Stock Performance

Shares of APPN stock opened at $33.79 on Thursday. The stock has a market capitalization of $2.89 billion, a P/E ratio of -27.70 and a beta of 1.61. The company has a 50 day moving average price of $36.61 and a 200 day moving average price of $34.03. Appian has a fifty-two week low of $26.28 and a fifty-two week high of $43.33.

Insider Buying and Selling

In other news, Director William D. Mccarthy sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $38.78, for a total transaction of $27,146.00. Following the completion of the sale, the director now owns 7,966 shares in the company, valued at approximately $308,921.48. The trade was a 8.08 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 44.00% of the stock is owned by insiders.

Institutional Trading of Appian

Institutional investors have recently modified their holdings of the stock. Barclays PLC lifted its position in shares of Appian by 285.9% during the 3rd quarter. Barclays PLC now owns 71,771 shares of the company’s stock worth $2,451,000 after buying an additional 53,172 shares during the last quarter. Abdiel Capital Advisors LP lifted its position in shares of Appian by 72.6% during the 3rd quarter. Abdiel Capital Advisors LP now owns 10,169,273 shares of the company’s stock worth $347,179,000 after buying an additional 4,278,969 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of Appian by 282.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 134,274 shares of the company’s stock worth $4,584,000 after buying an additional 99,198 shares during the last quarter. Empyrean Capital Partners LP purchased a new stake in shares of Appian during the 2nd quarter worth approximately $7,715,000. Finally, 272 Capital LP purchased a new stake in shares of Appian during the 2nd quarter worth approximately $2,179,000. Hedge funds and other institutional investors own 52.70% of the company’s stock.

Appian Company Profile

Appian Corporation, a software company that provides low-code design platform in the United States, Mexico, Portugal, and internationally. The company's platform offers artificial intelligence, process automation, data fabric, and process mining. It provides The Appian Platform, an integrated automation platform that enables organizations to design, automate, and optimize mission-critical business processes.